WHO ICTRP trial
Evaluation of the role of Lymphadenectomy In high-risk Prostate cancer SurgEry
ISRCTN14434966 · International Standard Randomised Controlled Trial Number (ISRCTN) · Recruiting
Key facts
| Trial ID | ISRCTN14434966 |
|---|---|
| Public title | Evaluation of the role of Lymphadenectomy In high-risk Prostate cancer SurgEry |
| Scientific title | A randomised controlled trial comparing the clinical and cost-effectiveness of lymph node removal in patients undergoing curative surgery for localised high-risk prostate cancer |
| Primary sponsor | Cardiff and Vale University Health Board |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | England;Scotland;United Kingdom;Wales |
| Conditions | Biopsy-proven clinically localised high-risk prostate cancer Cancer |
| Interventions | Participants will be identified through screening in local and regional specialist multi-disciplinary teams. Adult males with biopsy-proven clinically localised high-risk PCa, where the local multi-disciplinary review has identified them as… |
| Registration date | Jun 8, 2024 |
| Target size | 1080 |
| Secondary IDs | Nil known;Nil known;CPMS 63289, IRAS 329888, NIHR152686 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: